SAN FRANCISCO, July 4, 2022 /PRNewswire/ -- A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled "Small Molecule Drug Discovery - Global Market Trajectory & Analytics". The report presents fresh perspectives on opportunities and challenges in a significantly transformed post COVID-19 marketplace.
FACTS AT A GLANCE
What's New for 2022?
Global competitiveness and key competitor percentage market shares
Market presence across multiple geographies - Strong/Active/Niche/Trivial
Online interactive peer-to-peer collaborative bespoke updates
Access to our digital archives and MarketGlass Research Platform
Complimentary updates for one year
Edition: 9; Released: January 2022
Executive Pool: 5443
Companies: 21 - Players covered include AstraZeneca PLC; Boehringer Ingelheim International GmbH; Bristol-Myers Squibb Company; Gilead Sciences, Inc.; GlaxoSmithKline PLC; Johnson & Johnson; Merck & Co., Inc.; Pfizer, Inc.; Teva Pharmaceutical Industries Ltd. and Others.
Coverage: All major geographies and key segments
Segments: Process Phase (Target Id/Validation, Hit Generation and Selection, Lead Identification, Lead Optimization); Therapeutic Area (Oncology, Central Nervous System, Cardiovascular, Anti-Infective, Immunological, Other Therapeutic Areas)
Geographies: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.
Complimentary Project Preview - This is an ongoing global program. Preview our research program before you make a purchase decision. We are offering a complimentary access to qualified executives driving strategy, business development, sales & marketing, and product management roles at featured companies. Previews provide deep insider access to business trends; competitive brands; domain expert profiles; and market data templates and much more. You may also build your own bespoke report using our MarketGlass™ Platform which offers thousands of data bytes without an obligation to purchase our report. Preview Registry
Global Small Molecule Drug Discovery Market to Reach $41.8 Billion by 2026
Amid the COVID-19 crisis, the global market for Small Molecule Drug Discovery estimated at US$30.1 Billion, is projected to reach a revised size of US$41.8 Billion by 2026, growing at a CAGR of 5.5% over the analysis period. Oncology, one of the segments analyzed in the report, is projected to record a 6.7% CAGR and reach US$18.2 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Central Nervous System segment is readjusted to a revised 6% CAGR for the next 7-year period.
The U.S. Market is Estimated at $9.5 Billion in 2021, While China is Forecast to Reach $7.3 Billion by 2026
The Small Molecule Drug Discovery market in the U.S. is estimated at US$9.5 Billion in the year 2021. China, the world`s second largest economy, is forecast to reach a projected market size of US$7.3 Billion by the year 2026 trailing a CAGR of 5% over the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.3% and 4.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.3% CAGR.
Cardiovascular Segment to Reach US$1.6 Billion by the year 2026
In the global Cardiovascular segment, USA, Canada, Japan, China and Europe will drive the 5.4% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$917.5 Million will reach a projected size of US$1.3 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. More
Our MarketGlass™ Platform is a free full-stack knowledge center that is custom configurable to today`s busy business executive`s intelligence needs! This influencer driven interactive research platform is at the core of our primary research engagements and draws from unique perspectives of participating executives worldwide. Features include - enterprise-wide peer-to-peer collaborations; research program previews relevant to your company; 3.4 million domain expert profiles; competitive company profiles; interactive research modules; bespoke report generation; monitor market trends; competitive brands; create & publish blogs & podcasts using our primary and secondary content; track domain events worldwide; and much more. Client companies will have complete insider access to the project data stacks. Currently in use by 67,000+ domain experts worldwide.
About Global Industry Analysts, Inc. & StrategyR™
Global Industry Analysts, Inc., (www.strategyr.com) is a renowned market research publisher the world`s only influencer driven market research company. Proudly serving more than 42,000 clients from 36 countries, GIA is recognized for accurate forecasting of markets and industries for over 33 years.
Director, Corporate Communications
Global Industry Analysts, Inc.
Join Our Expert Panel
Connect With Us on LinkedIn
Follow Us on Twitter
Journalists & Media
View original content to download multimedia:https://www.prnewswire.com/news-releases/a-41-8-billion-global-opportunity-for-small-molecule-drug-discovery-by-2026---new-research-from-strategyr-301579408.html
SOURCE Global Industry Analysts, Inc.